G&G Biotechnology Overview
- Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
G&G Biotechnology General Information
Description
Developer of a lightweight breast implant for transforming the breast augmentation and reconstruction industry. The company's B-Lite implants are designed to reduce gravitational stress on the breast soft-tissue. These proprietary microsphere-enhanced silicone implants are built to retain the breast shape and form, while offering safety and aesthetic outcome.
Contact Information
Primary Industry
Therapeutic Devices
Acquirer
Primary Office
- Ashkelon
- Israel
G&G Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
G&G Biotechnology Patents
G&G Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3752097-A1 | Implants with enhanced shell adhesion | Pending | 18-Feb-2018 | 0000000000 | |
| EP-3752097-A4 | Implants with enhanced shell adhesion | Pending | 18-Feb-2018 | 0000000000 | 0 |
| US-20210361402-A1 | Implants with enhanced shell adhension | Pending | 18-Feb-2018 | 0000000000 | 0 |
| AU-2016230679-A1 | Composite implant material | Active | 12-Mar-2015 | 00000000 | |
| AU-2016230679-B2 | Composite implant material | Active | 12-Mar-2015 | A61F2/12 |
G&G Biotechnology Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jacky Govrin-Yehudain MD | Co-Founder & President | ||
| Eli Gendler | Chief Financial Officer |
G&G Biotechnology Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|